Study, Development and Rationale Use of Immunopharmacological Agents

Thursday, October 26th / 17.00-18.30
13 Glucocorticoi-Induced Leucine Zipper (GILZ) as a mediator of Antiinflammatory Effects of Glucocorticoids
Carlo Riccardi
144 Inhibitory receptors activation by antibodies on cancer cells: A new immunopharmacological weapon in our arsenal?
Francesca Levi-Schaffer
191 The emotional side of autoimmune disorders: a new venue for treatment?
Fulvio D'Acquisto
206 Towards a stratified targeted approach with biologic therapies in rheumatoid arthritis
Costantino Pitzalis